Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Devi Jaganathan
Observed name:
Jaganathan Devi
Institution:
University of Arizona
Observed institutions:
Nationwide Children's Hospital,
University of Arizona,
University of Connecticut,
Abigail Wexner Research Institute
ORCID:
0009-0000-3374-2391
Observed ORCID:
0009-0000-3374-2391
OpenAlex ID:
A5014018027
Impact of elexacaftor–tezacaftor–ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis
2022
·
Shahid Sheikh
, Rodney D. Britt
, et al.
·
Pediatric Pulmonology
·
102
PDF
Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor
2022
·
Shuzhong Zhang
, Chandra L. Shrestha
, et al.
·
European Respiratory Journal
·
60
PDF
Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis
2022
·
Devi Jaganathan
, Emanuela M. Bruscia
, et al.
·
International Journal of Molecular Sciences
·
20
PDF
Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity
2020
·
Gurusamy Umamaheswaran
, Dharanipragada Kadambari
, et al.
·
Breast Cancer Research and Treatment
·
13
Structure, Function, and Inhibition of Adenylosuccinate Lyase (ADSL) from Mycobacterium tuberculosis
2025
·
Vigyasa Singh
, Devi Jaganathan
, et al.
·
ACS Infectious Diseases
·
1
Assessment of Sentinel Lymph Node using Methylene Blue Dye in Carcinoma Breast
2015
·
Devi Jaganathan
Show more works
View as search
Works count:
6
Citation count:
196
H-index:
4
I10-index:
4
Year
Topic
Type